Suppr超能文献

肺癌诊断时症状的预后价值:一项为期三年的观察性研究。

Prognostic value of symptoms at lung cancer diagnosis: a three-year observational study.

作者信息

Polanco Dinora, Pinilla Lucía, Gracia-Lavedan Esther, Mas Anna, Bertran Sandra, Fierro Gemma, Seminario Asunción, Gómez Silvia, Barbé Ferrán

机构信息

Group of Translational Research in Respiratory Medicine, Hospital Universitari Arnau de Vilanova y Santa Maria, IRB Lleida, Lleida, Spain.

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

出版信息

J Thorac Dis. 2021 Mar;13(3):1485-1494. doi: 10.21037/jtd-20-3075.

Abstract

BACKGROUND

Lung cancer is mainly diagnosed at advanced or locally advanced stages, usually when symptoms become evident. However, sometimes it may be diagnosed incidentally during routine care, while patients are still asymptomatic. Prognosis differences based on symptomatic presentation have been partially explored. Our aim was to analyze the prognostic value of the initial symptomatic state of the patients in a general lung cancer cohort.

METHODS

Observational ambispective study including patients consecutively diagnosed with primary lung cancer between January 2016 and December 2018 via the lung cancer Fast Diagnostic Track (FDT). Patients were followed up until death or the end of the study in September 2019. Asymptomatic patients were compared with patients presenting symptoms. Overall survival (OS) of both groups was compared using the log-rank test. Cox regression analysis was performed to clarify the effect of the symptomatic status at diagnosis on survival. Additionally, propensity score (PS) matching analysis was performed.

RESULTS

A total of 267 patients were analyzed; 83.5% were men, with a mean (SD) age at diagnosis of 68 (10.7) years. Incidental diagnosis was ascertained in 24.7% of cases. Asymptomatic patients presented more frequently stage I and II disease compared to symptomatic patients (51.5% 14%), and exhibited a significantly better prognosis, with a 3-year OS of 63.6% ( 30.3%) and a median OS that was not reached during follow-up ( 10.3 months). With an adjusted multivariate Cox proportional hazard model, we obtained a HR (95% CI) of 2.63 (95% CI, 1.6-4.2; P<0.0001) associated with symptomatic presentation independently of age, sex, stage at diagnosis and ECOG scale. In addition, after performing the propensity score matching analysis, the Cox regression model continued to show a significantly worse prognosis for patients presenting with symptoms (P=0.041).

CONCLUSIONS

Lung cancer patients who are asymptomatic at diagnosis exhibit a significantly better prognosis, regardless of the stage of the disease, underlining the importance of an early diagnosis.

摘要

背景

肺癌主要在晚期或局部晚期被诊断出来,通常是在症状明显时。然而,有时它可能在常规检查中偶然被诊断出来,而此时患者仍无症状。基于症状表现的预后差异已得到部分研究。我们的目的是分析在一个普通肺癌队列中患者初始症状状态的预后价值。

方法

采用观察性双向研究,纳入2016年1月至2018年12月期间通过肺癌快速诊断通道(FDT)连续诊断为原发性肺癌的患者。对患者进行随访直至死亡或2019年9月研究结束。将无症状患者与有症状患者进行比较。使用对数秩检验比较两组的总生存期(OS)。进行Cox回归分析以阐明诊断时症状状态对生存的影响。此外,还进行了倾向评分(PS)匹配分析。

结果

共分析了267例患者;83.5%为男性,诊断时的平均(标准差)年龄为68(10.7)岁。24.7%的病例为偶然诊断。与有症状患者相比,无症状患者I期和II期疾病的发生率更高(51.5%对14%),并且预后明显更好,3年总生存率为63.6%(标准差30.3%),随访期间中位总生存期未达到(标准差10.3个月)。通过调整后的多变量Cox比例风险模型,我们获得了与有症状表现相关的风险比(95%置信区间)为2.63(95%置信区间,1.6 - 4.2;P<0.0001),独立于年龄、性别、诊断时的分期和ECOG量表。此外,在进行倾向评分匹配分析后,Cox回归模型继续显示有症状患者的预后明显更差(P = 0.041)。

结论

诊断时无症状的肺癌患者无论疾病分期如何,预后均明显更好,这突出了早期诊断的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/068b/8024804/1ad96f1cb96a/jtd-13-03-1485-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验